Home
Our Company
Management Team
Key Advisors/Consultants
Board of Directors
Scientific Advisory Board
Investors
Upcoming Events
Past Events
Our Products
AG200-15
AG900
Additional Patch Products
Publications
Press Room
Contact Us
Company News
Press Anouncements
2009 Archive
Agile Therapeutics Press Announcements
2012
AGILE THERAPEUTICS ANNOUNCES COMPLETION OF AG200-15 PHASE III CLINICAL PROGRAM
2011
AGILE RECOGNIZED AS THE LIFE SCIENCES COMPANY OF THE YEAR BY THE NEW JERSEY TECH COUNCIL
AGILE THERAPEUTICS ANNOUNCES UPCOMING PRESENTATIONS
AGILE THERAPEUTICS TO PRESENT AT THE BIOTECH SHOWCASE 2011
2010
AGILE THERAPEUTICS ANNOUNCES STUDY RESULTS DEMONSTRATING CONTRACEPTIVE PATCH AG200-15 DELIVERS A LOW DOSE OF ESTROGEN
AGILE THERAPEUTICS APPOINTS NEW PRESIDENT AND CEO AL ALTOMARI AS COMPANY PREPARES FOR COMMERCIALIZATION PHASE
AGILE THERAPEUTICS COMPLETES ENROLLMENT IN PHASE 3 NEW CHOICE STUDY OF AG200-15, AGILE'S NOVEL, LOW-DOSE WEEKLY CONTRACEPTIVE PATCH
AGILE THERAPEUTICS COMMENCES PHASE 3 NEW CHOICE STUDY OF AG200-15, AGILE'S NOVEL, LOW-DOSE WEEKLY CONTRACEPTIVE PATCH
AGILE THERAPEUTICS SECURES $45M IN SERIES B FUNDING TO PROGRESS LEAD CONTRACEPTIVE PATCH, AG200-15, THROUGH NDA FILING
2009 Archive